Muscle invasive bladder cancer
Chemoradiotherapy in octogenarians as primary treatment for muscle invasive bladder cancer
... medically unsuitable to undergo cystectomy for muscle- invasive bladder cancer (MIBC) and thus underwent com- bination chemoradiotherapy as primary therapy for their disease. In our centre, ...
7
Replacing surveillance cystoscopy with urinary biomarkers in followup of patients with non muscle invasive bladder cancer: Patients’ and urologic oncologists’ perspectives
... regarding bladder cancer ...with bladder cancer, your viewpoints on potential new diagnostic tools are important to ...non-muscle invasive bladder cancer are ...
18
Genomic characterization of high-risk non-muscle invasive bladder cancer
... non-muscle- invasive bladder cancer (HR-NMIBC) have not been ...to muscle- invasive or advanced ...metastatic bladder cancer (BC) were analyzed for ...
9
Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer
... Background: This study aims to prospectively evaluate the ability of Neutrophil-to-Lymphocyte ratio (NLR) to forecast recurrence in patients with non-muscle invasive bladder cancer (NMIBC). ...
10
Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol
... Introduction Survivors of muscle invasive bladder cancer (MIBC) experience physical and psychosocial side effects of cancer diagnosis and treatment. These negative side effects have a ...
7
Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
... Muscle-invasive bladder cancer is a heterogeneous disease with an overall poor prognosis ...a bladder preservation strategy is being pursued, chemoradiation may be offered as part of a ...
14
Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
... system, bladder cancer is ranked second both in incidence and mortality, and hence, a more accurate estimate of the prognosis for individual patients with non-muscle-invasive bladder ...
10
Perioperative chemotherapy for muscle invasive bladder cancer
... 38. Cognetti F, Ruggeri EM, Felici A, et al. Adjuvant chemotherapy (AC) with cisplatin+gemcitabine (CG) versus chemotherapy (CT) at relapse (CR) in patients (pts) with muscle-invasive bladder ...
5
Bladder preservation approach versus radical cystectomy for high grade non muscle invasive bladder cancer: a meta analysis of cohort studies
... non-muscle-invasive bladder cancer ...on Cancer (AJCC) staging system, also known as the tumor node metastases (TNM) classification ...non-muscle-invasive bladder ...
15
A case of isolated rectal recurrence of muscle invasive bladder cancer
... We illustrated some of the diagnostic and treatment related issues related to MIBC, specifically the need to investigate hematuria in the right clinical context and to offer neoadju- vant cisplatin based chemotherapy to ...
5
Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer: Mansoura Experience
... objective: Bladder preservation therapy (BPT) using a trimodality approach represents an alternative option to cystectomy inmuscle-invasive bladder cancer (MIBC) patients, also a treatment ...
7
Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
... Abstract: Bladder-sparing options are being developed for muscle-invasive bladder cancer in place of radical cystectomy, including the combination of chemotherapy and radiation ...to ...
10
Comprehensive analysis of aberrantly expressed profiles of lncRNAs and miRNAs with associated ceRNA network in muscle- invasive bladder cancer
... gastric cancer, hepatocellular cancer, breast cancer and pancreatic cancer ...in bladder cancer. Furthermore, comprehensive analysis of muscle- invasive ...
12
The management of BCG failure in non muscle invasive bladder cancer: an update
... non-muscle-invasive bladder cancer (NMIBC) will fail intravesical bacillus Calmette-Guérin (BCG) ...T1 bladder cancer and/or carcinoma in situ (CIS or TIS) is more problematic, ...
7
Optimal management of muscle-invasive bladder cancer – a review
... neoadjuvant MVAC was 77 months versus 46 months in those who underwent cystectomy alone (P = 0.06), with the cystec- tomy patients having a 33% higher risk of death than those receiving combination therapy (HR 1.33, 95% ...
9
CUA guidelines on the management of non muscle invasive bladder cancer
... A more recent study from Memorial Sloan-Kettering Cancer Center confirmed the need for restaging TURBT, especially in high-risk NMIBC. In a retrospective analysis of 1021 patients with high-risk NMIBC, Sfakianos ...
15
Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial.
... or bladder cancer death or after a second primary cancer diagnosis, (ii) excluding any patients with less than two years of follow-up and (iii) excluding any patients with major protocol violations ...
19
Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
... have revealed the prognostic value of various inflamma- tory factors such as albumin, C-reactive protein, Glasgow prognostic score, and prognostic index in cancer patients. The NLR represents an easily measured, ...
6
Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
... Two typical templates for chemoradiation were reported: split- or single-course protocol [5]. A split-course protocol consists of induction chemoradiation of 40-45 Gy, followed by evaluation of any residual tumor with ...
28
Clinical rationale and safety of restaging transurethral resection in indication stratified patients with high risk non muscle invasive bladder cancer
... detrusor muscle in the ...of Cancer (EORTC) ...lacking muscle, Tx (1) was defined as the presence of lamina propria invasion in a specimen without muscle, while specimens lacking both ...
6